InvestorsHub Logo
Followers 275
Posts 32779
Boards Moderated 0
Alias Born 11/14/2013

Re: exwannabe post# 454867

Monday, 03/28/2022 4:48:45 PM

Monday, March 28, 2022 4:48:45 PM

Post# of 711039
Duffy went back to Merck after helping UCLA with combination trial design and helped NWBO with the SAP, imo. The SAP help would have been essential, because Merck makes Temodar and they would have more access to ECA data than any other company in the world. Imo.

Yet another reason a BP looks like they are pulling the strings.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News